Proponents who promoted ivermectin as a COVID-19 cure are now circulating unproven claims that the antiparasitic drug treats hantavirus, following an outbreak linked to a cruise ship.
The shift reveals a persistent pattern among a subset of online activists and alternative health advocates. During the pandemic, these figures pushed ivermectin despite lack of clinical evidence, contradicting guidance from the FDA and medical establishments. Regulatory agencies approved the drug only for parasitic infections, not viral diseases. The promotion nonetheless gained traction among vaccine skeptics and those distrustful of mainstream medicine.
Hantavirus, a rare but serious infection spread through contact with infected rodent droppings, carries a mortality rate exceeding 30 percent in some cases. The recent cruise ship cluster triggered renewed public concern. Within days, the same networks that championed ivermectin for COVID began promoting it for hantavirus without peer-reviewed studies supporting such use.
Public health officials have not endorsed ivermectin for hantavirus treatment. The virus requires supportive care and monitoring in medical settings. No antiparasitic agent has proven effective against it in clinical trials.
The reemergence of ivermectin promotion underscores challenges health agencies face combating medical misinformation. False treatments delay people from seeking legitimate care and divert resources from proven prevention methods. For hantavirus, rodent control and proper sanitation remain the evidence-based approach to preventing infection.
The pattern also reflects how online communities sustain alternative health narratives across different health crises. Advocates who built followings promoting one unproven remedy readily transfer that messaging to new threats, regardless of scientific validity. Their credibility within these communities persists despite past claims lacking evidence.